AMRX
USDAmneal Pharmaceuticals Inc. Class A Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$11.010
고가
$11.400
저가
$10.940
거래량
3.47M
기업 기본 정보
시가총액
3.6B
산업
Drug Manufacturers - Specialty & Generic
국가
United States
거래 통계
평균 거래량
1.66M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.
Amneal Reports Third Quarter 2025 Financial Results
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's
